Alzheimer’s disease, which is one of the most common forms of dementia, affects millions worldwide, and early detection has ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

However, that could all change thanks to a new blood test called Lumipulse. On May 16, the U.S. Food & Drug Administration ...

The first Alzheimer's blood test cleared by the Food and Drug Administration is poised to change the way doctors diagnose and ...

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...